Key Points
Nov 9 (Reuters) - UnitedHealth's (UNH.N) pharmacy benefit manager unit said on Thursday it was adding eight insulin products to its reimbursement list that would limit out-of-pocket spend to $35 or less...
The unit, Optum Rx, will move eight products, including all short- and rapid-acting insulin, to tier one, or preferred status, which offers the lowest price for consumers and is effective Jan..
Novo Nordisk (NOVOb.CO) and Sanofi (SASY.PA) will have their insulin products added to the preferred status.. Pharmacy benefit managers act as middlemen and negotiate rebates and fees with drug manufacturers, create lists of medications that are covered by insurance and reimburse pharmacies for patients' prescriptions...
